The present invention is directed to particular monoclonal antibodies that find
use in the identification and purification of Sarcocystis neurona and related
antigens. In particular, these antibodies permit the diagnosis of Sarcocystis
related diseases such as equine protozoal myeloencephalitis (EPM).
